Clinical Trial

Topo-Pachymetric Customized Accelerated Epi-On Vs Accelerated Epi-Off Corneal Cross Linking in Keratoconus Management

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to compare the clinical effectiveness and safety of Topo-Pachymetric Customized Accelerated Epithelium-On (aCFXL) to Standard Accelerated Epithelium-Off (aCXL) Corneal Collagen Cross-Linking in the management of keratoconus. The study aims to evaluate visual and structural outcomes, to provide valuable insights into optimizing treatment strategies.
Trial Details
NCT Number NCT06549387
Lead Sponsor Kasr El Aini Hospital
Conditions Amount of Corneal Flattening (Kmax Flattening), Change in the Endothelial Cell Count
Enrollment 55 participants
Start Date 2024-08-15
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-12